Nuo Therapeutics Company
%20.jpg)
Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds. Nuo Therapeutics is headquartered in Gaithersburg, Maryland.
Total Funding:
$112.8M
Acquisitions Number:
1
Headquarters:
Gaithersburg, Maryland, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Technology:
Others
Investor Type:
For Profit
Investors Number:
3
Founded Date:
1987-01-01
Industry:
Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical, Therapeutics, Wellness